1-10 of 10
Koichi Sugimoto
Close
Sort by
Journal Articles

Approval Delay in Drugs from Non-Global Company in Europe and Japan: Analysis of Novel Drugs for Hematologic Malignancies

Kensuke Matsuda, Sumimasa Nagai, Koichi Sugimoto
Journal: Blood
Blood (2023) 142 (Supplement 1): 2332.
https://doi.org/10.1182/blood-2023-172848
Published: 2023
Journal Articles

Association between Hospital Volume and Early Mortality of Newly Diagnosed Acute Promyelocytic Leukemia: A Nationwide Database Study in Japan

Kensuke Matsuda, Taisuke Jo, Hideo Yasunaga, Koichi Sugimoto
Journal: Blood
Blood (2022) 140 (Supplement 1): 6069.
https://doi.org/10.1182/blood-2022-157471
Published: 2022
Journal Articles

Disease-Specific Analysis of Drug Approval Delay in Hematologic Malignancies between Japan and the U.S. and between Europe and the U.S

Kensuke Matsuda, Sumimasa Nagai, Koichi Sugimoto
Journal: Blood
Blood (2022) 140 (Supplement 1): 10801–10802.
https://doi.org/10.1182/blood-2022-155880
Published: 2022
Journal Articles

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

Makoto Hirokawa, MD PhD, Naohito Fujishima, MD, Masanao Teramura, MD, Kenichi Sawada, MD, Masami Bessho, MD, Kazuo Dan, MD, Hisashi Tsurumi, MD, Shinji Nakao, MD PhD, Akio Urabe, MD, Shin Fujisawa, MD PhD, Yuji Yonemura, MD PhD, Fumio Kawano, MD, Koichi Sugimoto, MD, Akira Matsuda, MD, Masamitsu Karasawa, MD, Ayako Arai, MD, PhD, Norio Komatsu, MD, Hideo Harigae, MD, Kaoru Tohyama, MD, Saito-Moriya Akiko, MD, Itaru Matsumura, MDPhD, Mitsuhiro Omine, MD, Keiya Ozawa, MD, Mineo Kurokawa, MD PhD, Shunya Arai, MD, Kinuko Mitani, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4954.
https://doi.org/10.1182/blood.V130.Suppl_1.4954.4954
Published: 2017
Journal Articles

The Long Form of Cellular FLIP Renders NK-Cell Lymphoma Cells Resistant to Fas-Mediated Apoptosis

Yasushi Isobe, MD, PhD, Azuchi Masuda, MD, Koichi Sugimoto, MD, PhD, Norio Komatsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4129.
https://doi.org/10.1182/blood.V128.22.4129.4129
Published: 2016
Journal Articles

miR-135b mediates NPM-ALK–driven oncogenicity and renders IL-17–producing immunophenotype to anaplastic large cell lymphoma

Hironori Matsuyama, Hiroshi I. Suzuki, Hikaru Nishimori, Masaaki Noguchi, Takashi Yao, Norio Komatsu, Hiroyuki Mano, Koichi Sugimoto, Kohei Miyazono
Journal: Blood
Blood (2011) 118 (26): 6881–6892.
https://doi.org/10.1182/blood-2011-05-354654
Published: 2011
Includes: Supplemental data
Journal Articles

The MDM2 Antagonist Nutlin-3 Is Effective to Aggressive NK-Cell Neoplasms with Wild Type p53 in Hypoxia

Yoko Tabe, MD, PhD, Yasushi Isobe, MD, PhD, Koichi Sugimoto, MD, PhD, Linhua Jin, PhD, Kazuo Oshimi, MD, Takashi Miida, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4999.
https://doi.org/10.1182/blood.V118.21.4999.4999
Published: 2011
Journal Articles

Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts

Kenji Tamayose, Koichi Sugimoto, Miki Ando, Kazuo Oshimi
Journal: Blood
Blood (2001) 97 (8): 2524–2525.
https://doi.org/10.1182/blood.V97.8.2524
Published: 2001
Journal Articles

P-Glycoprotein Expression on Normal and Abnormally Expanded Natural Killer Cells and Inhibition of P-Glycoprotein Function by Cyclosporin A and Its Analogue, PSC833

Motoki Egashira, Norihiko Kawamata, Koichi Sugimoto, Takako Kaneko, Kazuo Oshimi
Journal: Blood
Blood (1999) 93 (2): 599–606.
https://doi.org/10.1182/blood.V93.2.599
Published: 1999
Journal Articles

Temporal and Spatial Distribution of DNA Topoisomerase II Alters During Proliferation, Differentiation, and Apoptosis in HL-60 Cells

Koichi Sugimoto, Konagi Yamada, Motoki Egashira, Yoshio Yazaki, Hisamaru Hirai, Akihiko Kikuchi, Kazuo Oshimi
Journal: Blood
Blood (1998) 91 (4): 1407–1417.
https://doi.org/10.1182/blood.V91.4.1407
Published: 1998